Docket #: S13-244
Reagents to maintain stem cell pluripotency in ambient atmosphere
This invention provides a stem cell culture medium with small molecule inhibitors that can be used to maintain pluripotency in a laboratory atmospheric environment. Using these small molecules for stem cell culture may eliminate the need for the costly equipment needed to create a dedicated low-oxygen environment. The buffer was invented by Professor Jim Collman at Stanford University and Professor Christopher Navara at the University of Texas.
Stage of Research
This research is ongoing. Currently 12 compounds have been tested. These have been tested in human embryonic stem cells and are undergoing testing in other cell lines including other human cell types and pluripotent stem cells from other species.
Applications
- Stem cell culture - to grow cells and maintain pluripotency in pluripotent stem cells, human embryonic stem cells, or induced pluripotent stem cells
Advantages
- Ambient atmosphere - using mitochondrial inhibitors in growth medium maintains pluripotency:
- without low oxygen conditions
- without special containment and measurement equipment
Related Links
Patents
- Published Application: WO2015196139
- Published Application: 20170130198
Similar Technologies
-
Cross-reactive antibodies targeting NKp46 that enhance cytotoxicity and proliferation in both human and murine NK cells S23-217Cross-reactive antibodies targeting NKp46 that enhance cytotoxicity and proliferation in both human and murine NK cells
-
DMN-Tre: A probe for the rapid, simple, and specific detection of mycobacteria with applications for the rapid diagnosis of M. tuberculosis in sputum from TB patients. S16-097DMN-Tre: A probe for the rapid, simple, and specific detection of mycobacteria with applications for the rapid diagnosis of M. tuberculosis in sputum from TB patients.
-
Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens S20-312Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens